Biotech ends summer on a high 

Biotech finished on a high in August, according to San Francisco venture capital firm Burrill & Company.

The company’s Burrill Biotech Select Index closed up 4.4 percent on Friday before the Labor Day holiday weekend, said G. Steven Burrill, company CEO.

Top performers included Emeryville’s Onyx Pharmaceuticals (ONXX), up 42 percent, and Vertex Pharmaceuticals, up 21 percent.

About The Author

Staff Report

Staff Report

Bio:
A daily newspaper covering San Francisco, San Mateo County and serving Alameda, Marin and Santa Clara counties.
Pin It
Favorite

Speaking of Business

More by Staff Report

Latest in Business & Real Estate

© 2018 The San Francisco Examiner

Website powered by Foundation